Our analyses identified LOX and PPAR-γ as primary astroglial targets of lithium that are relevant to BD and schizophrenia, whilst flavonoids have potential astrocyte-modifying effects that are relevant to BD and AD (Table 1). This evidence concerns the gene LOX and Behcet disease.